Erratum: Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly (European Journal of Endocrinology (2004) 151:6 (309-315) DOI: 10.1530/eje.0.1510309);Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly

European Journal of Endocrinology

Volumn 151, Issue 3, 2004, Pages 309-315

  Herrmann, Burkhard L ^a   Wessendorf, T E ^a   Ajaj, W ^a   Kahlke, S ^a   Teschler, H ^a   Mann, K ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGE; AGED; ARTICLE; BODY MASS; BREATHING DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; FEMALE; FREQUENCY ANALYSIS; HORMONE DETERMINATION; HUMAN; MALE; NORMAL VALUE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RESPIRATORY TRACT PARAMETERS; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; TONGUE DISEASE; TREATMENT OUTCOME;

EID: 4744340728     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0694e     Document Type: Erratum

References (36)

1. Colao A, Cuocolo A, Marzullo P. Nicolai E, Ferone D, Della Morte AM, Petretta M, Salvatore M & Lombardi G. Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. Journal of Clinical Endocrinology and Metabolism 1999 84 1518-1523.
2. Colao A, Cuocolo A, Marzullo P. Nicolai E, Ferone D, Della Morte AM, Pivonello R, Salvatore M & Lombardi G. Is the acromegalic cardiomyopathy reversible, Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism 2001 86 1551-1557.
3. Herrmann BL, Bruch C, Saller B, Ferdin S, Dagres N, Ose C, Erbel R & Mann K. Occurrence of ventricular late potentials in patients with active acromegaly. Clinical Endocrinology 2001 55 201-207.
4. Herrmann BL, Bruch C, Saller B, Bartel T, Ferdin S, Erbel R & Mann K. Acromegaly: evidence foe a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy. Clinical Endocrinology 2002 56 595-602.
5. Herrmann BL, Brandt-Mainz K, Saller B, Bruch C, Wieneke H, Kugler C, Ferdin S, Hahn S, Erbel R, Bockisch A & Mann K. Myocardial perfusion abnormalities in patients with active acromegaly. Hormone and Metabolic Research 2003 35 183-188.
6. Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734.
7. Popovic V. Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z & Marinkovic J. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clinical Endocrinology 1998 49 441-445.
8. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F & Liuzzi A. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. Journal of Endocrinological Investigation 2002 25 240-245.
9. Herrmann BL, Baumann H, Janssen OE, Goerges R, Schmid KW & Mann K. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Experimental and Clinical Endocrinology and Diabetes 2004 112 225-284.
10. Grunstein RR, Ho KY & Sullivan CE. Sleep apnea in acromegaly. Annals of Internal Medicine 1991 115 527-532.
11. Grunstein RR. Ho KY. Berthon-Jones M, Stewart D & Sullivan CE. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. American Journal of Respiratory and Critical Care Medicine 1994 150 496-502.
12. Barkan A. Acromegalic arthropathy and sleep apnea. Journal of Endocrinology 1997 155 (Suppl 1) S41-S45 discussion S45.
13. Rosenow F, Reuter S, Deuss U, Szelies B, Hilgers RD, Winkelmann W & Heiss WD. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clinical Endocrinology 1996 45 563-569.
14. Isono S, Saeki N, Tanaka A & Nishino T. Collapsibility of passive pharynx in patients with acromegaly. American Journal of Respiratory and Critical Care Medicine 1999 160 64-68.
15. Grunstein RR, Ho KY, Berthon-Jones M, Stewart D & Sullivan CE. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. American Journal of Respiratory and Critical Care Medicine 1994 150 496- 502.
16. Hart TB, Radow SK, Blackard WG, Tucker HS & Cooper KR. Sleep apnea in active acromegaly. Archives of Internal Medicine 1985 145 865-866.
17. Grunstein RR, Ho KK & Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Annals of Internal Medicine 1994 121 478-483.
18. Lamberts SW, van Koetsveld P & Hofland L. A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivo. Clinical Endocrinology 1989 31 401-410.
19. Melmed S. Acromegaly. New England Journal of Medicine 1990 322 966-977.
20. Giustina A, Barkan A, Casanueva FF. Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K & Melmed S. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529.
21. Schwab RJ, Pasirstein M, Pierson R, Mackley A. Hachadoorian R, Arens R, Maislin G & Pack AI. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. American Journal of Respiratory and Critical Care Medicine 2003 168 522-530.
22. Stuck BA, Kopke J, Maurer JT, Verse T, Kuciak G. Duber C & Hormann K. Evaluating the upper airway with standardized magnetic resonance imaging. Laryngoscope 2002 112 552-558.
23. Gao XM, Zeng XL. Fu MK & Huang XZ. Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after oral appliance therapy. Chinese Journal of Dental Research 1999 2 27-35.
24. Hori T, Sugita Y. Koga E, Shirakawa S, Inoue K, Uchida S, Kuwahara H, Kousaka M, Kobayashi T, Tsuji Y, Terashima M, Fukuda K & Pukuda N. Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry and Clinical Neurosciences 2001 55 305-310.
25. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992 15 173-184.
26. Dostalova S, Smahel Z & Sonka K. Craniofacial abnormalities in sleep apnoea syndrome. Acta Chiurgica Plastica 1998 40 49-53.
27. Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J & Horinek D. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. European Journal of Endocrinology 2001 144 491-497.
28. Ip MS, Tan KC, Peh WC & Lam KS. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clinical Endocrinology 2001 55 477-483.
29. Bacon WH, Turlot JC, Krieger J & Stierle JL. Cephalometric evaluation of pharyngeal obstructive factors in patients with sleep apneas syndrome. Angle Orthodontist 1990 60 115-122.
30. Hochban W, Ehlenz K, Conradt R & Brandenburg U. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. European Respiratory Journal 1999 14 196-202.
31. Hochban W & Brandenburg U. Morphology of the viscerocranium in obstructive sleep apnoea syndrome - cephalometric evaluation of 400 patients. Journal of Cranio-Maxillofacial Surgery 1994 22 205-213.
32. Colao A, Marzullo P, Ferone D, Spinelli L, Cuocolo A, Bonaduce D, Salvatore M, Boerlin V, Lancranjan I & Lombardi G. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. Journal of Clinical Endocrinology and Metabolism 2000 85 3132-3140.
33. Colao A, Ferone D, Marzullo P & Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004 25 102-152.
34. Pekkarinen T, Partinen M, Pelkonen R & Iivanainen M. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clinical Endocrinology 1987 27 649-654.
35. Brummer RJ, Lonn L, Kvist H, Grangard U, Bengtsson BA & Sjostrom L. Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy. European Journal of Clinical Investigation 1993 23 199-205.
36. Sonksen PH, Salomon F & Cuneo R. Metabolic effects of hypopituitarism and acromegaly. Hormone Research 1991 36 (Suppl 1) 27-31.